Tadalafil NDC 51655-473

Product information

Brand name (proprietary)

Tadalafil

Generic name (nonproprietary)

tadalafil

Active ingredients

Tadalafil — 20 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Northwind Health Company, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209167

Marketing start

Nov 6, 2020

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 51655-473_490f1639-8284-d34e-e063-6394a90aa16eSPL ID 490f1639-8284-d34e-e063-6394a90aa16eSPL set ID f3092f5a-b976-91ab-e053-2995a90a9b50RxCUI 402019UNII 742SXX0ICT

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655047354 followed by a unit qualifier and the quantity Copy

Package 51655-0473-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209167

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.